Proactive - Interviews for investors

Sunstone Metals Ltd (ASX:STM) MD Malcolm Norris speaks with Proactive after receiving more high-grade gold exploration results from the Bramaderos project in southern Ecuador with trenches returning up to 18 metres at 4.8 g/t gold around 900 metres from Limon Central Shoot but still within the Limon epithermal discovery. He says the results indicate that Limon, which has already been established as a significant discovery, could be a very large gold-silver system by global standards with shallow, high-grade mineralisation.

#ProactiveInvestors #SunstoneMetals #ASX #Gold #BramaderosGoldProject #Ecuador

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Maximus Resources Ltd (ASX:MXR, OTC:MXRRF) MD Tim Wither speaks with Proactive following upgrades to the Hilditch and Larkinville mineral resource estimates which are part of the company’s 117 square kilometres Spargoville Project in Western Australia. Maximus now has combined group gold resources of 335,000 ounces. Wither says the process of completing the MRE updates has demonstrated the fantastic potential to continue to increase gold resources through targeted drilling at both Larkinville and Hilditch.

#ProactiveInvestors #MaximusResources #ASX #Gold #SpargovilleProject

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Sarytogan Graphite Ltd (ASX:SGA) MD Sean Gregory speaks with Proactive after announcing the first spheroidized graphite from the Sarytogan graphite deposit in Central Kazakhstan has been produced. Gregory says the company has complemented the ultra-high purity of 99.998% with these latest physical spheroidization results at high yields of ideally sized spheres. Sarytogan now heads into 2024 focused on measuring the battery performance of the products.

#ProactiveInvestors #SarytoganGraphite #ASX #Graphite #BatteryMetals #Kazakhstan

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

LTR Pharma Executive Chairman Lee Rodne joined Steve Darling from Proactive to share the exciting news that the company has initiated trading on the Australian Securities Exchange under the ticker symbol LTP. LTR Pharma is dedicated to improving men's health through the clinical development and commercialization of an innovative intranasal spray treatment for Erectile Dysfunction (ED). Rodne explained that their product, SPONTAN, distinguishes itself from existing ED therapies through its unique mechanism of action. It delivers an already proven, effective, and regulatory-cleared PDE5 inhibitor through intranasal delivery.

This approach is designed to bypass the first-pass metabolism associated with many oral PDE5 medications, offering potential benefits to patients. In addition to this milestone, Rodne highlighted that LTR Pharma has received approval from the Bellberry Human Research Ethics Committee for a bioequivalence clinical trial. This trial will compare SPONTAN with the FDA-approved ED drug Levitra, further advancing the company's efforts in the field of men's health. LTR Pharma's presence on the Australian Securities Exchange signifies an important step forward in its mission to provide innovative solutions for men facing erectile dysfunction, addressing a significant medical need and potentially offering improved treatment options.

Northstar Gold Corp's CEO, Brian Fowler joined Steve Darling from Proactive to provide an update on the company's recent financing and exploration activities. The company has successfully closed the first tranche of its non-brokered private placement, raising nearly $400,000 in funds. These funds will be allocated to support exploration efforts on several of Northstar's properties, with a specific focus on the historic high-grade Cam Copper Mine, located within the 100%-owned Miller Gold Property. Fowler explained that the company plans to conduct a down-hole EM geophysical survey from the 2023 Cam drill holes in early 2024.

Geophysical anomalies identified through this survey will be drill-tested as part of a Phase II Cam Copper diamond drill program scheduled for late February/early March 2024. In addition to this financing success, Fowler shared that Northstar Gold Corp has received an exploration grant from the Ontario Ministry, amounting to up to $80,532.50. This grant covers 50% of the company's critical minerals exploration expenditures at the Rosegrove Property, situated just south of Kirkland Lake, Ontario. The Rosegrove Property is highly prospective for shear and alkaline intrusion-related copper-gold deposits. Northstar is eagerly anticipating the results of recently completed LiDAR and Mobile Metal Ion soil surveys at this property in early 2024. These developments underscore Northstar Gold Corp's commitment to advancing its exploration projects and furthering its presence in the mining sector, particularly in the promising copper-gold domain.

Botala Energy Ltd (ASX:BTE) CEO Kris Martinick details the company’s goals and recent progress in an interview with Proactive.

Dual-listed on the Botswana and ASX stock exchanges, Botala is focused on diversifying energy sources, primarily using gas to transition to cleaner energy forms like solar and batteries.

It’s been a solid year of progress for the company, moving from IPO and exploration to appraisal, bringing gas to surface on more than one occasion, and now transitioning from a prospecting to a mining licence, with environmental approvals expected in the new year.

The company also achieved some operational refinements, reducing well drilling time on their licences from 45 days to 10.

#ProactiveInvestors #BotalaEnergy #EnergyTransition #SustainableEnergy #GasToRenewables #BotswanaEnergy #CleanEnergy #SolarPower #BatteryTechnology #ASXListed #EnergyStability #EnergyInnovation #GreenEnergy #EnergySector #RenewableResources #EcoFriendlyEnergy #EnergyEfficiency #EnergyDevelopment #GasExploration #EnergyAppraisal #FutureOfEnergy #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Jubilee Metals Group PLC (AIM:JLP, JSE:JBL, OTC:JUBPF) CEO Leon Coetzer speaks to Thomas Warner from Proactive at the end of a week Coetzer is happy to describe as "one of the most significant" in the metal recovery business' history.

Jubilee this week announced a deal with the Abu Dhabi-based International Resources Holding RSC (IRH) to acquire and jointly extract copper from a large waste rock dump in Zambia, where Jubilee aims to produce more than 20,000 tonnes per year of copper using its newly developed modular copper units.

Construction of processing units is planned to begin in the first quarter of 2024 and Jubilee said it has the capability to commission within 12 months. The AIM-listed company has also announced a £10mln placing specifically to fund the work.

Coetzer emphasises the project's scale, highlighting the opportunity to surpass the company's earlier copper production targets of 25,000 tonnes.

Additionally, the successful targeted capital raise, though dilutive, secures Jubilee's fully funded position for accelerated project execution. Coetzer also highlights the significance of this move, reducing the capital burden on Jubilee and positioning the company for a capital-light future with self-funding capabilities.

#ProactiveInvestors #JubileeMetals #copper #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #MiningIndustry #CopperMining #ZambiaMining #ResourceAcquisition #MiningPartnerships #GlobalMining #CopperResources #MiningStrategy #LeonCoetzer #InternationalHoldingsCorporation #IHCPartnership #MiningInvestments #GreenCopperProduction #MiningInnovation #SurfaceMining #MiningOperations #CopperProduction #StrategicMiningDevelopment #MiningSectorNews

Proactive Research analyst Ryan Long speaks to Thomas Warner after publishing a new report on exploration company Silver North Resources.

Silver North Resources says that it has made significant new silver discoveries in the Keno Hill Silver District of the Yukon at its Haldane Project, where high grade silver has been identified in drilling at three target areas. The Company also holds the Tim silver property in southern Yukon, where partner-funded exploration has identified high-grade silver mineralization just 19 km from the Silvertip mine.

Long gives an overview of the business and its current focus, before going on to say that Silver North's future plans involve comprehensive geophysics for better target generation and drilling to explore high-priority vein targets at both the Haldane and Tim projects.

#SilverNorthResources #SilverExploration #MiningIndustry #TSXVentureExchange #YukonMining #SilverInvestment #HaldaneProject #TimSilverProject #CoreMining #SilverMineralization #MiningStocks #ResourceExploration #GeophysicalSurveys #DrillingProgram #MiningNews #InvestmentOpportunities #ProactiveInvestors #ResourceAnalysts #SilverMarket #MiningTechnology #ProactiveInvestors #mining #silver #yukon #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major visits the Proactive London studio to speak with Thomas Warner about what he calls "the strangest year" in his career and "the worst relative performance for healthcare in 30 years."

He attributes the relatively poor performance of the sector to a series of negative macroeconomic and geopolitical events, including the collapse of Silicon Valley Bank, fluctuations in interest rates, and market overreaction to the advent of both AI and GLP-1 obesity drugs.

He believes the healthcare sector offers attractive growth at lower valuations compared to other markets, driven by consistent demand due to the inevitability of health issues.

The interview also delved into the broader implications of healthcare investments in an uncertain economic climate. Major positions healthcare is a defensive and intelligent choice, offering long-term growth regardless of economic conditions.

He also discusses the shift towards value-based care in the U.S., where healthcare providers are being incentivised to deliver positive patient outcomes, leading to more efficient resource allocation and better overall healthcare management.

Overall, Major's perspective offers a hopeful outlook for the healthcare sector in 2024, emphasising its resilience and growth potential amidst economic uncertainties.

#BellevueHealthcareTrust #HealthcareInvestment #HealthcareSector #PaulMajorInterview #EconomicAnalysis #InvestmentStrategies #HealthcareStocks #MarketTrends2023 #InvestorInsights #HealthcareTechnology #GlobalEconomy #StockMarketAnalysis #InvestmentOpportunities #HealthcareTrends #FinancialMarkets #EconomicOutlook #InvestmentAdvice #HealthcareFunding #EconomicImpact #PortfolioManagement

#ProactiveInvestors #health #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Neural Therapeutics Inc CEO Ian Campbell speaks to Thomas Warner from Proactive about his vision for revolutionising mental health treatment.

The company is working to develop medicines from from the San Pedro plant, in a challenge to traditional pharmaceutical methods that typically isolate single compounds.

Campbell, with a diverse background in physical sciences, biology, toxicology, and engineering, explains that he transitioned to this field driven by a desire to contribute positively to humanity. His journey reflects a commitment to lifelong education and a passion for impactful scientific innovation. The CEO's personal connection to mental health issues within his family further motivates his mission, receiving supportive feedback from his family on this career shift.

Currently, the company is focused on advancing their treatment into human clinical trials, navigating regulatory challenges and exploring the potential of botanicals in pharmaceuticals.

Campbell's goal is to fast-track the drug's development, backed by evidence of mescaline's efficacy in treating various mental ailments. He says success for him would be "our product being delivered to humans."

#NeuralTherapeutics #IanCampbell #MentalHealthInnovation #MescalineResearch #NaturalMedicine #Psychotherapy #MentalHealthAwareness #PharmaceuticalInnovation #HolisticHealth #SanPedroPlant #MentalWellness #ClinicalTrials #HealthcareLeadership #Biotechnology #MentalHealthAdvocacy #HealingJourney #ScienceAndWellness #TherapeuticBreakthrough #MentalHealthTreatment #HealthcareInnovation

#ProactiveInvestors #psychedelics #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews